Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Sacchi N, van Lint MT, Bosi A; Gruppo Italiano Trapianti Midollo Osseo (GITMO)..

Biol Blood Marrow Transplant. 2006 May;12(5):560-5.

2.

ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival.

Dugan MJ, DeFor TE, Steinbuch M, Filipovich AH, Weisdorf DJ.

Ann Hematol. 1997 Jul-Aug;75(1-2):41-6. Review.

PMID:
9322682
3.

Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.

Schwinghammer TL, Bloom EJ.

Clin Pharm. 1993 Oct;12(10):736-61. Review.

PMID:
8258255
4.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009159. doi: 10.1002/14651858.CD009159.pub2. Review.

PMID:
22972135
6.

Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.

Theurich S, Fischmann H, Chakupurakal G, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Rothe A, Scheid C, Hallek M, Skoetz N, von Bergwelt-Baildon M.

Crit Rev Oncol Hematol. 2013 Oct;88(1):178-86. doi: 10.1016/j.critrevonc.2013.03.009. Review.

PMID:
23561334
7.

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.

Remberger M, Aschan J, Barkholt L, Tollemar J, Ringdén O.

Clin Transplant. 2001 Jun;15(3):147-53. Review.

PMID:
11389703
8.

Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.

Jacobson P, Uberti J, Davis W, Ratanatharathorn V.

Bone Marrow Transplant. 1998 Aug;22(3):217-25. Review.

9.

Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation.

Mohty M, Gaugler B.

Best Pract Res Clin Haematol. 2010 Jun;23(2):275-82. doi: 10.1016/j.beha.2010.05.004. Review.

PMID:
20837339
10.

Bleeding complications after hematopoietic stem cell transplantation.

Pihusch M.

Semin Hematol. 2004 Jan;41(1 Suppl 1):93-100. Review.

PMID:
14872429
11.

Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.

Colby C, Stoukides CA, Spitzer TR.

Ann Pharmacother. 1996 Oct;30(10):1164-74. Review.

PMID:
8893124
12.

An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.

Margolis J, Vogelsang G.

Semin Oncol. 2000 Apr;27(2 Suppl 5):72-7. Review.

PMID:
10877057
13.
14.

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.

Bacigalupo A.

Bone Marrow Transplant. 2005 Feb;35(3):225-31. Review.

PMID:
15558041
15.

Graft-versus-host disease.

Bron D.

Curr Opin Oncol. 1994 Jul;6(4):358-64. Review.

PMID:
7803536
17.

Management of acute graft-versus-host disease.

Deeg HJ, Henslee-Downey PJ.

Bone Marrow Transplant. 1990 Jul;6(1):1-8. Review.

PMID:
2202460
18.

Antithymocyte globulin for prevention of graft-versus-host disease.

Bacigalupo A.

Curr Opin Hematol. 2005 Nov;12(6):457-62. Review.

PMID:
16217162
19.
20.

Chronic graft-versus-host disease.

Horwitz ME, Sullivan KM.

Blood Rev. 2006 Jan;20(1):15-27. Review.

PMID:
16426941
Items per page

Supplemental Content

Support Center